Bulk Production of Baculovirus Expressed Stable Virus Like  Particles of FMD Virus: Concentration, Purification and Semi Quantification

Authors

  • Das Adwitiya ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India https://orcid.org/0009-0000-2767-0416
  • Tilak Chandan S ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India https://orcid.org/0009-0005-5308-0512
  • Samriddhi Dubey ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India https://orcid.org/0009-0009-7457-6380
  • Lakshmikanth Katrapati ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India
  • Pankaj Dhakarwal ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India
  • Pallab Chaudhuri ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India
  • Paramasivam Saravanan ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru-560024, Karnataka, India https://orcid.org/0000-0002-6478-1278

DOI:

https://doi.org/10.48165/ijvsbt.21.3.11

Keywords:

Bulk production, Foot-and-mouth disease virus, Insect cells, Purification, Sucrose gradient, Virus-like

Abstract

 

The Virus-like Particles (VLPs) have the same epitopes as the native virus offering a great alternative to conventional vaccines due to the  lack of genome along with eliciting both arms of immunity. The thermostabilized Foot and Mouth Disease (FMD) VLP-based antigen  with inherent DIVA compatibility requires minimum biosafety and cold chain maintenance for the production and transit process. It  can potentially replace conventional virus handling during antigen production for prophylactic as well as diagnostic use. Preparation of  baculovirus expressed VLPs for vaccine formulation can be achieved by bulk production of VLPs in insect cell culture like Tn5 and Sf21  grown in a shaker incubator at standard conditions followed by concentration of the harvested cell culture supernatant and purification  by discontinuous sucrose density gradient with nine different gradients giving high yield. We standardized the bulk production of VLPs  in a refrigerated shaker incubator maintaining a temperature of 26°C, concentrated and purified it in simplified sucrose density gradient  ultracentrifugation, that could prove to serve as a potential vaccine candidate attributing to its thermostable properties.  

Downloads

Download data is not yet available.

References

Belsham, G.J. (1993). Distinctive features of foot-and-mouth disease virus, a member of the Picornavirus family: Aspects of virus protein synthesis, protein processing, and structure. Progress in Biophysics and Molecular Biology, 60, 241-260.

Bhat, S.A., Saravanan, P., Hosamani, M., Basagoudanavar, S.H., Sreenivasa, B.P., Tamilselvan, R.P., & Venkataramanan, R. (2013). Novel immunogenic baculovirus expressed virus-like particles

of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. Research in Veterinary Science, 95, 1217-1223. Deepak, P. R. S. (2022). Structure-based prediction to generate stable virus-like particles of foot-and-mouth disease virus serotype A and their characterization. PhD Thesis. Indian Veterinary Research Institute, Izatnagar, UP, India.

Dong, H., Guo, H.C., & Sun, S.Q. (2014). Virus-like particles in picornavirus vaccine development. Applied Microbiology and Biotechnology, 98(10), 4321-4329.

Ganji, V.K., Biswal, J.K., Lalzampuia, H., Basagoudanavar, S.H., Saravanan, P., Tamil Selvan, R.P., Umapathi, V., Reddy, G.R., Sanyal, A., & Dechamma, H.J. (2018). Mutation in the VP2

gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O. Applied Microbiology and Biotechnology, 102(20), 8883-8893.

Grubman, M.J., Moraes, M.P., Diaz-San Segundo, F., Pena, L., & de los Santos, T. (2008). Evading the host immune response: How foot and-mouth disease virus has become an effective pathogen. FEMS Immunology and Medical Microbiology, 53, 8-17.

Grubman, M.J., Zellner, M., Bablanian, G., Mason, P.W., & Piccone, M.E. (1995). Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology, 213, 581-589.

Madhavan, A., Dhanesh, V.V., Selvaraj, D.P.R., Gopinath, S., Sreenivasa, B.P., Tamil Selvan, R.P., Sanyal, A., Thiyagarajan, S., & Saravanan, P. (2021). An optimized protocol for purification of virus-like particles of foot-and-mouth disease virus produced in the baculovirus expression system. The Pharma Innovation Journal, 10(10S), 33-37.

Madhavan, A., Paramasivam, S., Dhanesh, V.V., Selvaraj, D.P.R., Shreya, G., Adwitiya, D., Madhusudan, H., Sreenivasa, B.P., Tamilselvan, R.P., Sanyal, A., Goyal, S., Thiyagarajan, S., & Chaudhuri, P. (2024). Diagnostic and prophylactic potential of a stabilized foot-and-mouth disease serotype asia1 virus like particles designed through a structure guided approach. International Journal of Biological Macromolecules, 277(4), 134366.

Ruiz, V., Baztarrica, J., Rybicki, E.P., Meyers, A.E., &Wigdorovitz, A. (2018). Minimally processed crude leaf extracts of Nicotiana benthamiana containing recombinant foot and mouth disease virus-like particles are immunogenic in mice. Biotechnology Reports, 20, e00283.

Sharma, A.K., Bhatt, M., Sankar, M., Mohapatra, J.K., Dash, B.B., Gowane, G.R., Subramaniam, S., Ranjan, R., & Pattnaik, B. (2018). Kinetics of interferon gamma and interleukin-21 response following foot and mouth disease virus infection. Microbial Pathogenesis, 125, 20-25.

Published

2025-05-10

How to Cite

Adwitiya, D., Chandan S, T., Dubey, S., Katrapati, L., Dhakarwal, P., Chaudhuri, P., & Paramasivam, S. (2025). Bulk Production of Baculovirus Expressed Stable Virus Like  Particles of FMD Virus: Concentration, Purification and Semi Quantification. Indian Journal of Veterinary Sciences and Biotechnology, 21(3), 53–57. https://doi.org/10.48165/ijvsbt.21.3.11